By Cynthia Kim and Hyunjoo Jin SEOUL, July 7 (Reuters) - U.S. chip design giant Synopsys plans to stop offering a suite of ...
InvestorsHub on MSN
Synopsys to phase out chip manufacturing software as AI design becomes strategic focus (SNPS)
Synopsys shifts resources away from manufacturing software Synopsys (NASDAQ:SNPS) is preparing to discontinue a suite of ...
Even after 20 years or so, process control continues to be a confusing or misunderstood technology. A short description of process control is an accurate one—It’s a means of controlling manufacturing ...
Synopsys is preparing to discontinue a suite of manufacturing process control software used by semiconductor manufacturers, ...
Validate it? I just want to use it! Sound familiar? Most companies in the medical device industry understand and accept the need to validate software that is critical to the functioning of a medical ...
BOSTON & TAMPA, Fla.--(BUSINESS WIRE)--TA, a leading global growth private equity firm with more than four decades of enterprise software investing experience, in partnership with ST6, an elite team ...
A medical device manufacturer ditched a clunky ERP module for quality inspection, opting instead for specialized statistical process control software. Upgrading to new software costs time and money ...
Increasingly tight tolerances and rigorous demands for quality are forcing chipmakers and equipment manufacturers to ferret out minor process variances, which can create significant anomalies in ...
Synopsys plans to stop offering manufacturing process control software. This move allows the company to divert resources to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results